Subtotal: $34,895.00
Subtotal: $34,895.00
Original price was: $2,999.00.$2,849.00Current price is: $2,849.00.
In Stock
Kisqali is indicated for the treatment of postmenopausal women with hormone receptor-positive (HR+) and human epidermal growth factor receptor type 2 receptor-negative (HER2-) advanced or metastatic breast cancer.
Active ingredient: ribociclib
Prescription medicine
